| Literature DB >> 31653432 |
José Bellver1, Ernesto Bosch1, Juan José Espinós2, Francisco Fabregues3, Juan Fontes4, Juan García-Velasco5, Joaquín Llácer6, Antonio Requena5, Miguel Angel Checa7.
Abstract
Second-generation preimplantation genetic testing for aneuploidy (PGT-A 2.0) in patients with an unfavourable reproductive and IVF prognosis is becoming common practice, with the aim of improving reproductive outcomes. However, there is still no clear evidence on the possible advantages and drawbacks with regard to this procedure. In this discussion paper, based on a SWOT (strengths, weaknesses, opportunities, threats) analysis, the different aspects of this strategy are evaluated. Current evidence suggests that PGT-A 2.0 should not at present have an indiscriminate application, but it might be indicated in cases in which the risk of aneuploidy is increased.Entities:
Keywords: Assisted reproduction; Blastocyst biopsy; Implantation; Infertility; Live birth; Preimplantation genetic testing
Year: 2019 PMID: 31653432 DOI: 10.1016/j.rbmo.2019.07.037
Source DB: PubMed Journal: Reprod Biomed Online ISSN: 1472-6483 Impact factor: 3.828